For: | Ren LL, Mao T, Meng P, Zhang L, Wei HY, Tian ZB. Glutamine addiction and therapeutic strategies in pancreatic cancer. World J Gastrointest Oncol 2023; 15(11): 1852-1863 [PMID: 38077649 DOI: 10.4251/wjgo.v15.i11.1852] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v15/i11/1852.htm |
Number | Citing Articles |
1 |
Sridevi Mardham, Soumya Dakshinamurthy. Immune Therapy for Pancreatic and Colon Cancers. 2025; : 325 doi: 10.1016/B978-0-443-24742-2.00001-0
|
2 |
Xiangpeng Kong, Haiqin Ren, Ke Pei, Yajun Yao, Zhigang Liang, Yunfeng Xue, Shuang Liang, Tongtong Li, Jing Zhang, Yuxia Guo, Miaorong Pei, Huifeng Li. Unveiling therapeutic targets and preventive components for kidney insufficiency and blood stasis-type BPH: bridging metabolomics, network pharmacology and reverse screening. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1584766
|
3 |
Dong-Hwan Kim, Dong Joon Kim, Seong-Jun Park, Won-Jun Jang, Chul-Ho Jeong. Inhibition of GLS1 and ASCT2 Synergistically Enhances the Anticancer Effects in Pancreatic Cancer Cells. Journal of Microbiology and Biotechnology 2025; 35 doi: 10.4014/jmb.2412.12032
|
4 |
Yan Zhang, Wancheng Li, Jubao Niu, Zeyang Fan, Xin Li, Hui Zhang. Reprogramming of glucose metabolism in pancreatic cancer: mechanisms, implications, and therapeutic perspectives. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1586959
|
5 |
Huanyu Wang, Yang Gui, Ke Lv. Molecular Imaging: Unveiling Metabolic Abnormalities in Pancreatic Cancer. International Journal of Molecular Sciences 2025; 26(11): 5242 doi: 10.3390/ijms26115242
|
6 |
Fatima I. AlMaazmi, Lara J. Bou Malhab, Leen ElDohaji, Maha Saber-Ayad. Deciphering the Controversial Role of TP53 Inducible Glycolysis and Apoptosis Regulator (TIGAR) in Cancer Metabolism as a Potential Therapeutic Strategy. Cells 2025; 14(8): 598 doi: 10.3390/cells14080598
|